Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances CI Q1 2026 Earnings EPS Misses Estimates as Stock Gains on Underlying Strength SKY Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction ARW Q1 2026 Earnings Stellar EPS Surpasses Estimates by Over 80 Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development Cheche Group CCG Q4 2024 Earnings EPS Beats Estimates by 4012 Revenue Not Reported